Sung Sook Lee

发表

Sung Sook Lee, 2003 .

Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.

Sung Sook Lee, Tae Won Kim, H. Chang, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Study of Cetuximab (Erbitux®) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer

Sung Sook Lee, Tae Won Kim, H. Chang, 2007, Journal of Korean medical science.

A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of the UGT1A1 and CYP2A6 Polymorphisms on Clinical Activity

Sung Sook Lee, Tae Won Kim, H. Chang, 2012, Oncology.

Salvage Chemotherapy With Biweekly Irinotecan, Plus 5-Fluorouracil and Leucovorin in Patients With Advanced Gastric Cancer Previously Treated With Fluoropyrimidine, Platinum, and Taxane

Sung Sook Lee, Tae Won Kim, H. Chang, 2008, American journal of clinical oncology.

A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer

Sung Sook Lee, Tae Won Kim, H. Chang, 2011, Cancer Chemotherapy and Pharmacology.

A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer: A Prospective, Multicenter Trial of the Korean Cancer Study Group

Sung Sook Lee, Tae Won Kim, Tae-You Kim, 2014, American journal of clinical oncology.

Brain metastases in breast cancer: prognostic factors and management

Sung Sook Lee, Sung-Bae Kim, S. Ahn, 2008, Breast Cancer Research and Treatment.

Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.

Sung Sook Lee, Kyung-Ja Cho, Sung-Bae Kim, 2007, Japanese journal of clinical oncology.

Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer

Sung Sook Lee, H. Chang, Yoon-Koo Kang, 2010, Cancer Chemotherapy and Pharmacology.

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

Sung Sook Lee, Tae Won Kim, H. Chang, 2007, Japanese journal of clinical oncology.

A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction

Sung Sook Lee, Tae Won Kim, H. Chang, 2011, Investigational New Drugs.

A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer

Sung Sook Lee, H. Chung, W. Hyung, 2012, Investigational New Drugs.

Safety and feasibility of adjuvant chemotherapy with S-1 in Korean patients with curatively resected advanced gastric cancer.

Sung Sook Lee, Yoon-Koo Kang, Kab-Choong Kim, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and Safety of S-1 Monotherapy in Patients with Advanced Biliary Tract Adenocarcinoma

Sung Sook Lee, H. Chang, Myung-Hwan Kim, 2009, Oncology.

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing

Jae Woo Choi, Sung Sook Lee, Keunchil Park, 2019, PloS one.

Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)

Sung Sook Lee, J. Shih, T. Hsia, 2022, The oncologist.

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity

Sung Sook Lee, J. Huh, C. Suh, 2007, Annals of Hematology.

Monoclonal Proteinuria as a Prognostic Factor for Multiple Myeloma Patients with Intact Immunoglobulin Type

Sung Sook Lee, Seong-Ho Choi, S. Sym, 2007 .

Intracranial anti-tumor activity of lazertinib in patients with advanced NSCLC who progressed after prior EGFR TKI therapy: Data from a phase I/II study.

Sung Sook Lee, M. Ahn, E. Cho, 2020 .

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

Sung Sook Lee, H. Chang, Yoon-Koo Kang, 2008, Cancer Chemotherapy and Pharmacology.

A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11).

Sung Sook Lee, S. Lim, B. Cho, 2022, Clinical lung cancer.

Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Sung Sook Lee, Dae-Ho Lee, C. Kim, 2010, Investigational New Drugs.

Both-sided intra-atrial intracardiac metastases as the initial presentation of testicular seminoma.

Sung Sook Lee, Yoon-Koo Kang, Sang-We Kim, 2007, Japanese journal of clinical oncology.

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer

Sung Sook Lee, Tae Won Kim, H. Chang, 2010, Cancer Chemotherapy and Pharmacology.

Rituximab‐ESHAP as a mobilization regimen for relapsed or refractory B‐cell lymphomas: a comparison with ESHAP

Sung Sook Lee, Dae-Ho Lee, J. Huh, 2007, Transfusion.

A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection

Sung Sook Lee, Dae-Ho Lee, J. Huh, 2007, Journal of clinical apheresis.

Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced gastric or gastroesophageal junction cancer from JAVELIN solid tumor phase Ib trial: Analysis of safety and clinical activity.

Sung Sook Lee, B. Melichar, Yoon-Koo Kang, 2016 .

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer

You Won Lee, Sung Sook Lee, A. Drilon, 2020, Clinical Cancer Research.

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Sung Sook Lee, F. Shepherd, Dong-Wan Kim, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.